TrialBMC cancer2023

Prolonged usage of fosaprepitant for prevention of delayed chemotherapy-induced nausea and vomiting(CINV) in patients receiving highly emetogenic chemotherapy.

Ai Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.